These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2155130)

  • 1. Acidic phospholipids directly inhibit DNA binding of mammalian DNA topoisomerase I.
    Tamura H; Ikegami Y; Ono K; Sekimizu K; Andoh T
    FEBS Lett; 1990 Feb; 261(1):151-4. PubMed ID: 2155130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Escherichia coli DNA topoisomerase I activity by phospholipids.
    Mizushima T; Natori S; Sekimizu K
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):503-6. PubMed ID: 1322135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serum level of tumor necrosis factor in animals treated with lipopolysaccharide and liposomes containing phosphatidylserine.
    Monastra G; Bruni A
    Lymphokine Cytokine Res; 1992 Feb; 11(1):39-43. PubMed ID: 1576245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
    Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
    Hsiang YH; Hertzberg R; Hecht S; Liu LF
    J Biol Chem; 1985 Nov; 260(27):14873-8. PubMed ID: 2997227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex.
    Hertzberg RP; Caranfa MJ; Hecht SM
    Biochemistry; 1989 May; 28(11):4629-38. PubMed ID: 2548584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation of the malarial phosphatidylserine decarboxylase is mediated by high affinity binding to anionic phospholipids.
    Choi JY; Lopes L; Ben Mamoun C; Voelker DR
    J Biol Chem; 2023 May; 299(5):104659. PubMed ID: 36997087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I.
    Das BB; Sen N; Roy A; Dasgupta SB; Ganguly A; Mohanta BC; Dinda B; Majumder HK
    Nucleic Acids Res; 2006; 34(4):1121-32. PubMed ID: 16488884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human DNA topoisomerase IB by a cyclometalated gold III compound: analysis on the different steps of the enzyme catalytic cycle.
    Castelli S; Vassallo O; Katkar P; Che CM; Sun RW; Desideri A
    Arch Biochem Biophys; 2011 Dec; 516(2):108-12. PubMed ID: 22033340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific phospholipids are required to reconstitute adenylate cyclase solubilized from rat brain.
    Hebdon GM; LeVine H; Sahyoun NE; Schmitges CJ; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):120-3. PubMed ID: 6941240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of DNA topoisomerases by microbial inhibitors.
    Suzuki K; Siddique T; Nishimura H; Sekimoto J; Uyeda M
    J Enzyme Inhib; 1998 Feb; 13(1):41-55. PubMed ID: 9879513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
    Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M
    Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction.
    Wu Y; Wang KY; Li Z; Liu YP; Izumi H; Uramoto H; Nakayama Y; Ito K; Kohno K
    J Exp Clin Cancer Res; 2014 Dec; 33(1):112. PubMed ID: 25539742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrostatin, a novel macromolecular inhibitor of topoisomerases produced by Streptomyces avermitilis no. C-127.
    Suzuki K; Sekimoto J; Siddique T; Kamiya A; Uyeda M
    J Enzyme Inhib; 1998; 14(1):69-83. PubMed ID: 10520760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.
    Hsiang YH; Liu LF
    Cancer Res; 1988 Apr; 48(7):1722-6. PubMed ID: 2832051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by phospholipids, lysophospholipids and gangliosides of melittin-induced phosphorylation in bovine mammary gland.
    Katoh N
    Toxicology; 1995 Dec; 104(1-3):73-81. PubMed ID: 8560504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of mammalian DNA topoisomerase I-mediated DNA cleavage and DNA winding by bulgarein.
    Fujii N; Yamashita Y; Saitoh Y; Nakano H
    J Biol Chem; 1993 Jun; 268(18):13160-5. PubMed ID: 8390457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced stabilization of covalent DNA topoisomerase I-DNA intermediates. DNA cleavage assays.
    Fiorani P; Hann CL; Benedetti P; Bjornsti MA
    Methods Mol Biol; 2001; 95():291-301. PubMed ID: 11089241
    [No Abstract]   [Full Text] [Related]  

  • 19. pH-dependent regulation of camptothecin-induced cytotoxicity and cleavable complex formation by the antimalarial agent chloroquine.
    Sorensen M; Sehested M; Jensen PB
    Biochem Pharmacol; 1997 Aug; 54(3):373-80. PubMed ID: 9278096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA demethylation protects from cleavable complex stabilization and DNA strand breakage induced by the topoisomerase type I inhibitor camptothecin.
    Orta ML; Mateos S; Cortés F
    Mutagenesis; 2009 May; 24(3):237-44. PubMed ID: 19201781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.